Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487

[1]  J. Proost,et al.  Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates. , 1993, Journal of chromatography.

[2]  K.,et al.  Time Course of Action and Endotracheal Intubating Conditions of Org 9487, a New Short‐Acting Steroidal Muscle Relaxant; A Comparison with Succinylcholine , 1993, Anesthesia and analgesia.

[3]  J. Proost,et al.  Design of drugs for rapid onset , 1993 .

[4]  P. Hennis,et al.  Intubating conditions and onset of neuromuscular block of rocuronium (Org 9426); a comparison with suxamethonium , 1992, Acta anaesthesiologica Scandinavica.

[5]  J. Wierda,et al.  Clinical Pharmacokinetics of Neuromuscular Blocking Drugs , 1992, Clinical pharmacokinetics.

[6]  K. Nakao,et al.  ELEVATED ENDOTHELIN-1 LEVEL IN CEREBROSPINAL FLUID OF PATIENTS WITH SUBARACHNOID HEMORRHAGE , 1991 .

[7]  Y. Ohta,et al.  The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia. , 1991, Anesthesiology.

[8]  J. Wierda,et al.  Dose‐Response Relation, Neuromuscular Blocking Action, Intubation Conditions, and Cardiovascular Effects of Org 9273, a New Neuromuscular Blocking Agent , 1991, Anesthesia and analgesia.

[9]  L. Booij,et al.  The neuromuscular blocking effect of Org 9426 , 1991, Anaesthesia.

[10]  J. Wierda,et al.  The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl , 1991, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[11]  William H. Press,et al.  Numerical recipes , 1990 .

[12]  K. Kuizenga,et al.  Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent. , 1990, British journal of anaesthesia.

[13]  W. Bowman,et al.  Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. , 1989, British journal of anaesthesia.

[14]  A. Kopman.  Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency? , 1989, Anesthesiology.

[15]  R. Hall,et al.  Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid? , 1988, Anesthesiology.

[16]  W. Bowman,et al.  Structure: action Relationships Among Some Desacetoxy Analogues of Pancuronium and Vecuronium in the Anesthetized Cat , 1988, Anesthesiology.

[17]  S. Ágoston.  Pharmacological profile of neuromuscular blocking agents: present and future trends. , 1988, Acta anaesthesiologica Belgica.

[18]  N. Nussmeier,et al.  An Assessment of Statistics , 1986 .

[19]  C. Meistelman,et al.  Disposition and Urinary Excretion of Vecuronium Bromide in Anesthetized Patients with Normal Renal Function or Renal Failure , 1986, Anesthesia and analgesia.

[20]  A. Scaf,et al.  Comparative Pharmacokinetics and Dynamics of Vecuronium and Pancuronium in Anesthetized Patients , 1986, Anesthesia and analgesia.

[21]  H. Drexler,et al.  [Modification of organ perfusion by calcium blocker and converting enzyme inhibitor in the conscious rat with heart failure]. , 1985, Klinische Wochenschrift.

[22]  G. Scholtysik,et al.  Effects of the New Calcium Antagonist PN 200–110 on the Myocardium and the Regional Peripheral Circulation in Anesthetized Cats and Dogs , 1984, Journal of cardiovascular pharmacology.

[23]  Chingmuh Lee.  Succinylcholine: Its past, present, and future , 1984 .

[24]  D. Armstrong,et al.  The kinetics of tubocurarine action and restricted diffusion within the synaptic cleft. , 1979, The Journal of physiology.

[25]  John G. Wagner,et al.  Fundamentals of Clinical Pharmacokinetics , 1975 .